OAM
Oppenheimer Asset Management Portfolio holdings
AUM
$8.72B
This Quarter Return
+7.75%
1 Year Return
+19.29%
3 Year Return
+71.82%
5 Year Return
+126.54%
10 Year Return
+242.9%
AUM
$7.54B
AUM Growth
+$7.54B
(+7.2%)
Cap. Flow
+$108M
Cap. Flow
% of AUM
1.43%
Top 10 Holdings %
Top 10 Hldgs %
15.04%
Holding
1,277
New
87
Increased
543
Reduced
595
Closed
49
Top Buys
| 1 |
Intuitive Surgical
ISRG
|
$20.9M |
| 2 |
iShares Currency Hedged MSCI EAFE ETF
HEFA
|
$18.7M |
| 3 |
iShares Russell 1000 Value ETF
IWD
|
$17.8M |
| 4 |
Vanguard FTSE All-World ex-US ETF
VEU
|
$14.8M |
| 5 |
iShares Core S&P US Growth ETF
IUSG
|
$13.7M |
Top Sells
| 1 |
Autodesk
ADSK
|
$8.83M |
| 2 |
Meta Platforms (Facebook)
META
|
$7.75M |
| 3 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
$7.64M |
| 4 |
iShares Russell 2000 Growth ETF
IWO
|
$7.46M |
| 5 |
iShares MSCI EAFE Growth ETF
EFG
|
$7.45M |
Sector Composition
| 1 | Technology | 21.31% |
| 2 | Healthcare | 13.85% |
| 3 | Financials | 13.14% |
| 4 | Consumer Discretionary | 10.29% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
NextEra Energy, Inc.
NEE
$148B
| $29.6M | 0.39% | 317,341 -2,115 | -0.7% | -$197K |
|
52
Novartis
NVS
$245B
| $29.2M | 0.39% | 333,332 +1,198 | +0.4% | +$105K |
|
|
53
iShares Russell 1000 Value ETF
IWD
$63.5B
| $29.1M | 0.39% | 173,046 +106,146 | +159% | +$17.8M |
|
54
Truist Financial
TFC
$60.4B
| $28.6M | 0.38% | 487,853 +16,073 | +3% | +$941K |
|
55
Walt Disney
DIS
$213B
| $28M | 0.37% | 180,783 +7,118 | +4% | +$1.1M |
|
56
General Dynamics
GD
$87.3B
| $27.7M | 0.37% | 132,709 +2,278 | +2% | +$475K |
|
|
57
Autodesk
ADSK
$67.3B
| $27.6M | 0.37% | 98,027 -31,392 | -24% | -$8.83M |
|
58
Danaher
DHR
$147B
| $26.9M | 0.36% | 81,760 +2,241 | +3% | +$737K |
|
59
Novo Nordisk
NVO
$251B
| $26.2M | 0.35% | 234,069 +2,876 | +1% | +$322K |
|
60
Oracle
ORCL
$635B
| $26.1M | 0.35% | 299,067 +3,706 | +1% | +$323K |
|
61
Lumen
LUMN
$5.1B
| $25.8M | 0.34% | 2,053,032 -80,714 | -4% | -$1.01M |
|
62
Align Technology
ALGN
$10.3B
| $25.6M | 0.34% | 38,937 +3,519 | +10% | +$2.31M |
|
63
Target
TGT
$43.6B
| $25.5M | 0.34% | 110,253 +250 | +0.2% | +$57.9K |
|
64
CVS Health
CVS
$92.8B
| $25.3M | 0.34% | 244,997 +9,011 | +4% | +$930K |
|
65
Johnson Controls International
JCI
$69.9B
| $25.2M | 0.33% | 310,351 +1,363 | +0.4% | +$111K |
|
66
Chubb
CB
$110B
| $25.2M | 0.33% | 130,436 +1,279 | +1% | +$247K |
|
67
West Pharmaceutical
WST
$17.8B
| $24.6M | 0.33% | 52,353 +61 | +0.1% | +$28.6K |
|
|
INFO
68
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $24.5M | 0.32% | 184,277 -6,306 | -3% | -$838K |
|
69
Five Below
FIVE
$8B
| $24.3M | 0.32% | 117,338 -369 | -0.3% | -$76.3K |
|
70
Genuine Parts
GPC
$19.4B
| $24.2M | 0.32% | 172,471 +2,708 | +2% | +$380K |
|
71
Bristol-Myers Squibb
BMY
$96B
| $23.9M | 0.32% | 383,618 +50,301 | +15% | +$3.14M |
|
72
AT&T
T
$209B
| $23.4M | 0.31% | 950,304 -162,880 | -15% | -$4.01M |
|
73
BCE
BCE
$23.3B
| $23.3M | 0.31% | 447,074 -10,716 | -2% | -$558K |
|
74
Gartner
IT
$19B
| $22.9M | 0.3% | 68,623 +719 | +1% | +$240K |
|
75
Thermo Fisher Scientific
TMO
$186B
| $22.8M | 0.3% | 34,143 -75 | -0.2% | -$50K |
|